# Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder

> **NCT07433413** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Shenzhen Sciencare Medical Industries Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07433413
- **Lead sponsor:** Shenzhen Sciencare Medical Industries Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433413, "Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07433413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*